Venture Certified
| 벤처투자유형 | 2023-01-25 ~ 2026-01-24 | 20230125010048 | 2023-01-25 |
| 벤처투자유형 | 2026-01-25 ~ 2029-01-24 | 20251223010044 | 2023-01-25 |
Revenue CAGR +933.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 105B | 10B | 0.0B |
| Operating Profit | 11B | 0.6B | -3.1B |
| Net Profit | -4.2B | 0.1B | -3.1B |
| Total Assets | 205B | 101B | 12B |
| Total Liabilities | 164B | 83B | 0.3B |
| Total Equity | 40B | 17B | 11B |
Debt Ratio 409.0%: Exceeds 400%, financial soundness risk
▲ 1967.7%
▲ 976.7%
▲ 96.3%
▲ 69.6%
▲ 20.9%
| Name | Position | Role |
|---|---|---|
| 김승찬 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울 서초구",
"ceo_name": "김승찬",
"certificate": [
{
"cert_number": "20230125010048",
"changes": "",
"disclosure_date": "2023-01-25",
"first_cert_date": "2023-01-25",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2023-01-25 ~ 2026-01-24"
},
{
"cert_number": "20251223010044",
"changes": "",
"disclosure_date": "2025-12-23",
"first_cert_date": "2023-01-25",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2026-01-25 ~ 2029-01-24"
}
],
"company_name": "(주)이을바이오사이언스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 11094000,
"cost_of_sales": 0,
"current_assets": 855717000,
"current_liabilities": 28640000,
"gross_profit": 0,
"net_income": -307540000,
"net_income_bs": -307540000,
"non_current_assets": 298383000,
"non_current_liabilities": 0,
"non_operating_expenses": 5000,
"non_operating_income": 3669000,
"operating_profit": -311204000,
"revenue": 0,
"sga_expenses": 311204000,
"total_assets": 1154100000,
"total_equity": 1125460000,
"total_liabilities": 28640000
},
"2023": {
"capital_stock": 11228000,
"cost_of_sales": 378100000,
"current_assets": 2842958000,
"current_liabilities": 7670996000,
"gross_profit": 637679000,
"net_income": 10572000,
"net_income_bs": 10572000,
"non_current_assets": 7241920000,
"non_current_liabilities": 674850000,
"non_operating_expenses": 47670000,
"non_operating_income": 2969000,
"operating_profit": 55273000,
"revenue": 1015779000,
"sga_expenses": 582406000,
"total_assets": 10084878000,
"total_equity": 1739032000,
"total_liabilities": 8345846000
},
"2024": {
"capital_stock": 11227000,
"cost_of_sales": 4798127000,
"current_assets": 11697248000,
"current_liabilities": 2925247000,
"gross_profit": 5703701000,
"net_income": -424909000,
"net_income_bs": -425821000,
"non_current_assets": 8766015000,
"non_current_liabilities": 13517883000,
"non_operating_expenses": 1555768000,
"non_operating_income": 9025000,
"operating_profit": 1121834000,
"revenue": 10501828000,
"sga_expenses": 4581867000,
"total_assets": 20463263000,
"total_equity": 4020133000,
"total_liabilities": 16443130000
}
},
"industry": "화장품 제조업",
"investment": [
{
"amount": "414,000,000",
"changes": "414,000,000",
"date": "2022-11-22"
},
{
"amount": "414,000,000",
"changes": "414,000,000",
"date": "2022-11-22"
}
],
"main_products": "줄기세포 유래 엑소좀",
"phone": "02-536-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |